Trouble reading this email? View it in your browser
European Federation of Pharmaceutical industries and associations
   

EFPIA Newsletter 2 February 2023

 
 
 
   

Why Europe must future-proof its pharma legislation

 
Why Europe must future-proof its pharma regulation
31 January 2023
Despite a rich history in the discovery of new treatments and vaccines, Europe is going backwards when it comes to medical innovation. As a region, we have been falling behind global competitors in R&D and manufacturing, with lower investment, fewer clinical trials and longer approval times for new medicines for the last 25 years.

We have one shot at making Europe an innovation hub. Failure is not an option. Read more


 
 
 
   

News

 

EFPIA update on the readiness for mandatory use of the Clinical Trials Regulation
31 January 2023

A majority of EFPIA members have already submitted at least one clinical trial application through the Clinical Trials... Read more

EBC & EFPIA hold RETHINKING Alzheimer’s event ahead of policy paper launch
30 January 2023

The European Brain Council (EBC), in collaboration with EFPIA, organised a digital event looking at the need to rethink... Read more

 
 
 
   

Why Europe must future-proof its pharma legislation

 
 
 
 
   

Events

 

Impacts of IVDR Implementation on Patient Access to Clinical Trials
07 February 2023 (Online)

While the IVDR establishes a new regulatory framework for diagnostic tests in the EU to ensure test accuracy and patient... Read more

Time to act: Building a pharmaceutical framework fit for rare diseases
08 February 2023 (European Parliament, 60 Rue Wiertz, 1047, Bruxelles)

Join MEP Stelios Kympouropoulos in discussing the once-in-a-generation revision of the European pharmaceutical framework... Read more

ACCELERATE 2023 Annual Conference
09 February 2023 (Brussels & online)

All sessions, including Breakout Sessions, will be available for both in-person and online participants. Read more

AMR: New incentives – a call for action
15 February 2023 (Virtual)

The webinar will discuss the need for new economic pull incentives that can lead to the development of new and novel... Read more

 
 
 
   

What we are reading

 
Why EU capitals fear Brussels has got Ukraine’s hopes too high
On 01 February 2023 (Financial Times)

Nathalie Moll, EFPIA DG, comments the EU Commission idea to reduce patent protection to reverse the competitive decline... Read more

Requests for EMA PRIME designation fall but improvements are on the way
On 26 January 2023 (Pink Sheet)

EFPIA suggests reasons for the drop in PRIME applications, including the rejection rate. Read more